Skip to main content

Table 6 Patient characteristics

From: New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease

Group (n)

Age ± SEM

M + F

MMSE ± SEM

Non AD (28)

68.9 ± 2.0

14 + 14

23.5 ± 0.7

AD (32)

72.4 ± 1.6

12 + 19

19.3 ± 1.0 **

  1. AD: patients with Alzheimer’s disease; non-AD: patients with other dementias; M: male; F: female. MMSE: mini mental state examination. **: p < 0.01.